Search

espanolSe analiza la incidencia del tipo de cancer y sus principales manifestaciones en la etapa terminal mediante la mineria de datos. Se analizaron 288 datos de 22 pacientes, los cuales proporciono la unidad de cuidados paliativos del Hospital Regional 1° de Octubre. Las variables evaluadas fueron genero, ano, edad, diagnostico y sintoma. Para la clasificacion se utilizo el algoritmo J48 correspondiente al algoritmo C4.5. La mayor incidencia de mortalidad, de acuerdo con el tipo de cancer, se da en el de pulmon, colon, recto, mama y el de prostata. En cuanto al dolor, se presenta en mayor medida en pacientes jovenes, mientras que en pacientes de 65 anos o menos 39% y solo en 23% de los restantes. EnglishThe objective of this work is to analyze the incidence of the type of cancer and its main manifestations in the terminal stage through data mining. We analyzed 288 data from 22 patients, provided by the Palliative Care Unit of the Hospital Regional 1 de Octubre. The evaluated variables were gender, year, age, diagnosis and symptom. The algorithm J48 corresponding to the algorithm C4.5 was used for the classification. The highest incidence of mortality according to the type of cancer is highlighted: lung, colon, rectum, breast and prostate. As for pain, it is higher in young patients, while in patients aged 65 or less, 39% and only 23% of the rest

Background Preventive analgesia is the administration of an analgesic drug with the aim of attenuating post-operative pain, hyperalgesia and allodynia. Its use is justified in order to offer analgesia and reduce anxiety in patients undergoing laparoscopic procedures. Objective To evaluate if pregabalin in a dose of 1 mg/kg of weight is effective as preventive analgesia in post-operated laparoscopic cholecystectomy patients. Methods A single-blind controlled clinical trial was conducted, which included 60 patients scheduled for laparoscopic cholecystectomy randomly divided into 2 groups, where Group 1 received placebo and Group 2 received pregabalin a daily dose 72 h prior to surgical intervention. The intensity of pain was assessed using the numeric analog scale at 1, 2, 6, 12 and 24 post-operative h, as well as the level of presurgical anxiety with the Hamilton scale. Results Pain reduction was demonstrated in patients in the pregabalin group from the 1st h (p = 0.002), later the decrease in pain was more noticeable compared to patients who were given placebo (p < 0.001), the same happened with the anxiety level evaluated with the Hamilton scale (p < 0.005). Conclusion The use of pregabalin as preventive analgesia turns out to be effective in the post-operative period and the pre-operative anxiety with minimal adverse effects in the post-operated patients of laparoscopic cholecystectomy.

Preventive analgesia is the administration of an analgesic drug with the aim of attenuating post-operative pain, hyperalgesia and allodynia. Its use is justified in order to offer analgesia and reduce anxiety in patients undergoing laparoscopic procedures.To evaluate if pregabalin in a dose of 1 mg/kg of weight is effective as preventive analgesia in post-operated laparoscopic cholecystectomy patients.A single-blind controlled clinical trial was conducted, which included 60 patients scheduled for laparoscopic cholecystectomy randomly divided into 2 groups, where Group 1 received placebo and Group 2 received pregabalin a daily dose 72 h prior to surgical intervention. The intensity of pain was assessed using the emergency nurses association scale at 2, 6, 12 and 24 post-operative h, as well as the level of presurgical anxiety with the Hamilton scale.Pain reduction was demonstrated in patients in the pregabalin group from the 1The use of pregabalin as preventive analgesia turns out to be effective in the post-operative period and the pre-operative anxiety with minimal adverse effects in the post-operated patients of laparoscopic cholecystectomy.La analgesia preventiva es la administración de un fármaco analgésico con el objetivo de atenuar el dolor postoperatorio, la hiperalgesia y alodinia. Está justificado su uso con la finalidad de ofrecer analgesia y disminuir la ansiedad a los pacientes sometidos a procedimientos laparoscópicos.Evaluar si la pregabalina en dosis de 1 mg/kg de peso es eficaz para analgesia preventiva en pacientes postoperados de colecistectomía laparoscópica.Se realizó un ensayo clínico controlado ciego simple que incluyó 60 pacientes programados para colecistectomía laparoscópica divididos en 2 grupos de manera aleatoria, donde al grupo 1 se administró placebo y al grupo 2 se le administró pregabalina una dosis diaria 72 horas previas a la intervención quirúrgica. La intensidad del dolor se evaluó mediante la Escala Numérica Analógica a la hora, 2, 6,12 y 24 horas postoperatorias, así como el nivel de ansiedad prequirúrgico con la Escala de Hamilton.Se demostró disminución del dolor en los pacientes del grupo de pregabalina desde la primera hora (p = 0.002), posteriormente fue más notorio el descenso del dolor en comparación con los pacientes a los que se les dio placebo, con valor estadísticamente significativo (p0.001), lo mismo sucedió con el nivel de ansiedad evaluada con la Escala de Hamilton (p0.005).El uso de pregabalina para analgesia preventiva resulta ser eficaz en la ansiedad preoperatoria y el periodo posquirúrgico, y con mínimos efectos adversos, en los pacientes operados de colecistectomía laparoscópica.

Background Postoperative hypothermia is a common cause of complications in patients who underwent laparoscopic cholecystectomy. Hypothermia is known to elicit electrophysiological, biochemical, and cellular alterations thus leading to changes in the active and passive membrane properties. These changes might influence the bioelectrical impedance (BI). Our aim was to determine whether the BI depends on the core temperature. Methods We studied 60 patients (52 female and 8 male) age 40 to 80 years with an ASA I-II classification that had undergone laparoscopic cholecystectomy under balanced inhalation anesthesia. The experimental group (n = 30) received active core rewarming during the transanesthetic and postanesthesic periods. The control group (n = 30) received passive external rewarming. The BI was recorded by using a 4-contact electrode system to collect dual sets of measurements in the deltoid muscle. The body temperature, hemodynamic variables, respiratory rate, blood-gas levels, biochemical parameters, and shivering were also measured. The Mann-Whitney unpaired t-test was used to determine the differences in shivering between each group at each measurement period. Measurements of body temperature, hemodynamics variables, respiratory rate, and BI were analyzed using the two-way repeated-measures ANOVA. Results The gradual decrease in the body temperature was followed by the BI increase over time. The highest BI values (95 ± 11 Ω) appeared when the lowest values of the temperature (35.5 ± 0.5°C) were reached. The active core rewarming kept the body temperature within the physiological range (over 36.5°C). This effect was accompanied by low stable values (68 ± 3 Ω) of BI. A significant decrease over time in the hemodynamic values, respiratory rate, and shivering was seen in the active core-rewarming group when compared with the controls. The temporal course of shivering was different from those of body temperatue and BI. The control patients showed a significant increase in the serum-potassium levels, which were not seen in the active-core rewarming group. Conclusions The BI analysis changed as a function of the changes of core temperature and independently of the shivering. In addition, our results support the beneficial use of active core rewarming to prevent accidental hypothermia.